https://www.nst.com.my/world/world/2021/11/744691/indias-covid-19-vaccine-covaxin-highly-efficacious-lancet
0
0
42 words
0
Comments
PARIS: Covaxin, the first Covid-19 vaccine developed in India, is “highly efficacious” and presents no safety concerns, according to a study published in the Lancet on Thursday.
You are the first to view
Create an account or login to join the discussion